» Articles » PMID: 38105464

The "3 Ps" of EmPowerment, Partnership and Protection - Stakeholder Perceptions of Beneficial Outcomes of Engagement in HIV Prevention Trials

Overview
Specialty Medical Ethics
Date 2023 Dec 18
PMID 38105464
Authors
Affiliations
Soon will be listed here.
Abstract

Stakeholder engagement is increasingly recognized as a key component of ethical research in leading ethics guidelines. Ethics commentators have also argued that engagement has several beneficial outcomes for the field. This paper reports on the beneficial outcomes of stakeholder engagement in HIV prevention trials as perceived by stakeholders in the field. We conducted 28 interviews between 2019 and 2021 with interviewees from various stakeholder groups in 12 countries and used thematic analysis to analyze the transcripts. We found three major themes - namely where engagement is perceived to empower stakeholders, where engagement is perceived to build equitable relationships and where engagement is perceived to strengthen protections for participants and community stakeholders and to improve science. These findings map closely onto beneficial outcomes envisaged by ethics guidelines, however, the relationship between outcomes seen as beneficial deserves further exploration.

Citing Articles

Grounded in Reality: Integrating Community Values and Priorities of End Users in Human Gene Editing.

Riggan K, Feys R, Kokayi A, Meagher K, Michie M, Musunuru K Am J Bioeth. 2024; 24(8):43-45.

PMID: 39158441 PMC: 11335314. DOI: 10.1080/15265161.2024.2361880.

References
1.
Hickey G, Porter K, Tembo D, Rennard U, Tholanah M, Beresford P . What Does "Good" Community and Public Engagement Look Like? Developing Relationships With Community Members in Global Health Research. Front Public Health. 2022; 9:776940. PMC: 8830293. DOI: 10.3389/fpubh.2021.776940. View

2.
Asuquo S, Tahlil K, Muessig K, Conserve D, Igbokwe M, Chima K . Youth engagement in HIV prevention intervention research in sub-Saharan Africa: a scoping review. J Int AIDS Soc. 2021; 24(2):e25666. PMC: 7876473. DOI: 10.1002/jia2.25666. View

3.
Liu C, Meyers K . Beyond clinical trials: social outcomes of structured stakeholder engagement in biomedical HIV prevention trials in China. Cult Health Sex. 2019; 22(12):1365-1381. PMC: 7205565. DOI: 10.1080/13691058.2019.1683230. View

4.
MacQueen K, Eley N, Frick M, Ruiz Mingote L, Chou A, Seidel S . Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials. J Empir Res Hum Res Ethics. 2016; 11(3):203-13. PMC: 5389451. DOI: 10.1177/1556264616657452. View

5.
Adhikari B, Pell C, Cheah P . Community engagement and ethical global health research. Glob Bioeth. 2020; 31(1):1-12. PMC: 6968663. DOI: 10.1080/11287462.2019.1703504. View